Results 41 to 50 of about 47,605 (207)
Managing Acinetobacter baumannii infections
Current Opinion in Infectious Diseases, 2019 Purpose of review We reviewed recent data about epidemiology of Acinetobacter baumannii, resistance mechanisms, and therapeutic options for severe infections caused by multidrug-resistant strains. Recent findings A.
Garnacho-Montero, José +1 more
openaire +3 more sources
Treatment of Acinetobacter baumannii
, 2023 Acinetobacter baumannii is a Priority 1 pathogen under the WHO list for research and discovery of new antibiotics. The epidemiology of the pathogen suggests its relevance as an important “healthcare-associated” pathogen—with the most common clinical syndrome being ventilator-associated pneumonia.
Anup R. Warrier, Sneha Radha
openaire +1 more source
Insights into Acinetobacter baumannii protective immunity
Frontiers in Immunology, 2022 Acinetobacter baumannii is a nosocomic opportunistic Gram-negative bacteria known for its extensive drug-resistant phenotype. A. baumannii hospital-acquired infections are major contributors to increased costs and mortality observed during the COVID-19 pandemic.
Sean Jeffreys +6 more
openaire +3 more sources
Multidrug-ResistantAcinetobacter baumannii
Emerging Infectious Diseases, 2005 To understand the epidemiology of multidrug-resistant (MDR) Acinetobacter baumannii and define individual risk factors for multidrug resistance, we used epidemiologic methods, performed organism typing by pulsed-field gel electrophoresis (PFGE), and conducted a matched case-control retrospective study.
Aharon Abbo +5 more
openaire +3 more sources
Iron and Acinetobacter baumannii Biofilm Formation [PDF]
Pathogens, 2014 Acinetobacter baumannii is an emerging nosocomial pathogen, responsible for infection outbreaks worldwide. The pathogenicity of this bacterium is mainly due to its multidrug-resistance and ability to form biofilm on abiotic surfaces, which facilitate long-term persistence in the hospital setting. Given the crucial role of iron in A.
Gentile V +5 more
openaire +3 more sources
Multidrug-resistant Acinetobacter baumannii clones persist on hospital inanimate surfaces
Brazilian Journal of Infectious Diseases, 2018 Acinetobacter baumannii is one of the most frequent Gram-negative opportunistic pathogens associated with hospital-acquired infection worldwide. We briefly describe A.
Igor Vasconcelos Rocha +4 more
doaj +1 more source
Animal Research and One Health, EarlyView.This study firstly isolated a tuna‐derived gut probiotic Acinetobacter seifertii YFT067. Dietary administration of YFT067 played significant roles in promoting growth performance, SCFAs production, lipid absorption, and metabolism of the host, indicating YFT067 as a promising probiotic candidate for enhancing tuna aquaculture productivity through ...
Ying Zou +4 more
wiley +1 more source
Journal of Nepal Health Research CouncilBackground: Acinetobacter baumannii has emerged as a problematic pathogen due to its ability to become resistant to antibiotics and form biofilms.
Poonam Yadav +7 more
doaj +1 more source
SAGE Open Medicine, 2021 Background: The management of Acinetobacter baumannii infection is considered a challenge especially in an intensive care setting. The resistance rate makes it difficult to manage and is believed to lead to higher mortality.
Thabit Alotaibi +5 more
doaj +1 more source
Antibacterial Activity of Heteropolytungstates Against Proteus mirabilis
European Journal of Inorganic Chemistry, EarlyView.We investigated the in vitro antibacterial activity of several heteropolytungstates against P. mirabilis, a drug‐resistant pathogen. All tested polyanions inhibited bacterial growth, with the Preyssler–Pope–Jeannin polyanion P5W30 exhibiting the highest activity (MIC = 0.78 mg/mL).
Nour El Ghouch +5 more
wiley +1 more source